Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement

References

• TiedeDJNishimuraRAGastineauDAModern management of prosthetic valve anticoagulationMayo Clin Proc19987376656809663198
   PubMed Web of Science ®Google Scholar
• EikelboomJWWallentinLConnollySJRisk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trialCirculation2011123212363237221576658
   PubMed Web of Science ®Google Scholar
• TranACheng-LaiADabigatran etexilate: the first oral anticoagulant available in the United States since warfarinCardiol Rev201119315416121464643
   PubMed Web of Science ®Google Scholar
• LiewADouketisJInitial and long-term treatment of deep venous thrombosis: recent clinical trials and their impact on patient managementExpert Opin Pharmacother201314438539623414222
   PubMed Web of Science ®Google Scholar
• ArendtCJHongJHDalyRCTime to achieving therapeutic international normalized ratio increases hospital length of stay after heart valve replacement surgeryAm Heart J2017187707728454810
   PubMed Web of Science ®Google Scholar
• AkhtarRPAbidARZafarHKhanJSAniticoagulation in patients following prosthetic heart valve replacementAnn Thorac Cardiovasc Surg2009151101719262444
   PubMed Web of Science ®Google Scholar
• DzeshkaMSLipGYWarfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillationExpert Opin Drug Saf2015141456225341529
   PubMed Web of Science ®Google Scholar
• WuLChangQWangTZhangZLouYClinical observation of postoperative warfarin anticoagulation in 300 patients undergoing mitral valve replacement with a carbomedics mechanical valveHeart Surg Forum20151826366
   Web of Science ®Google Scholar
• LiedtkeMDRathbunRCDrug interactions with antiretrovirals and warfarinExpert Opin Drug Saf20109221522320095918
   PubMed Web of Science ®Google Scholar
• KuceraTMalyRUrbanKSponerPVenous Thromboembolism Prophylaxis after Total Hip ArthroplastyActa Chir Orthop Traumatol Cechoslov201178101105
   Web of Science ®Google Scholar
• LeitePMMartinsMAPCastilhoROReview on mechanisms and interactions in concomitant use of herbs and warfarin therapyBiomed Pharmacother201683142127470545
   PubMed Web of Science ®Google Scholar
• YinonYSiuSCWarshafskyCUse of low molecular weight heparin in pregnant women with mechanical heart valvesAm J Cardiol200910491259126319840573
   PubMed Web of Science ®Google Scholar
• NadkarniAOldhamMHowardMLazarHLBerenbaumIDetrimental effects of divalproex on warfarin therapy following mechanical valve replacementJ Card Surg201126549249421859435
   PubMed Web of Science ®Google Scholar
• WenMSLeeMTWarfarin Pharmacogenetics: New Life for an Old DrugActa Cardiol Sin201329323524227122712
   PubMed Web of Science ®Google Scholar
• CraigJAChaplinSJenksMWarfarin monitoring economic evaluation of point of care self-monitoring compared to clinic settingsJ Med Econ201417318419024351064
   PubMedGoogle Scholar
• FritzscheDSchenkSEitzTPatient self-monitoring of prosthetic heart valve functionJ Heart Valve Dis200716555856617944129
   PubMed Web of Science ®Google Scholar
• AucarJADoarnCRSargsyanAUse of the Internet for long-term clinical follow-upTelemed J19984437137410220478
   PubMedGoogle Scholar
• ShalanskySLyndLRichardsonKIngaszewskiAKerrCRisk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysisPharmacotherapy20072791237124717723077
   PubMed Web of Science ®Google Scholar
• NutescuEAShapiroNLIbrahimSWestPWarfarin and its interactions with foods, herbs and other dietary supplementsExpert Opin Drug Saf20065343345116610971
   PubMed Web of Science ®Google Scholar
• WongRSChengGChanTYUse of herbal medicines by patients receiving warfarinDrug Saf200326858558812825970
   PubMed Web of Science ®Google Scholar
• FanolaCLMooneyDCowanAJIncidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulantsAm Heart J201718415015528224930
   PubMed Web of Science ®Google Scholar
• IhaddadeneRCarrierMThe use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safetyExpert Opin Drug Saf2016151657426568174
   PubMed Web of Science ®Google Scholar
• ChuaiJBShiLMaXYCurative effect of mechanical heart valve replacement and anticoagulant therapy after surgeryJ Biol Regul Homeost Agents201630114114627049085
   PubMed Web of Science ®Google Scholar
• ZivelinARaoLVRapaportSIMechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factorsJ Clin Invest1993925213121408227329
   PubMed Web of Science ®Google Scholar
• BereznickiLRPetersonGMJacksonSLJeffreyECThe risks of warfarin use in the elderlyExpert Opin Drug Saf20065341743116610970
   PubMed Web of Science ®Google Scholar
• ClarkNPDelateTRiggsCSWarfarin interactions with antibiotics in the ambulatory care settingJAMA Intern Med2014174340941624445404
   PubMed Web of Science ®Google Scholar
• NishimuraRAOttoCMBonowRO2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice GuidelinesCirculation201713525e1159e119528298458
   PubMed Web of Science ®Google Scholar
• Lanas-GimenoALanasARisk of gastrointestinal bleeding during anticoagulant treatmentExpert Opin Drug Saf201716667368528467190
   PubMed Web of Science ®Google Scholar
• CruessDGLocalioARPlattABPatient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinicsInt J Behav Med2010171334219579066
   PubMed Web of Science ®Google Scholar
• El-GatitAMEl-GatitASHawMRelationship between depression and non-adherence to anticoagulant therapy after valve replacementEast Mediterr Health J200391–2121915562728
   PubMedGoogle Scholar
• MozosIStoianDLucaCTCrosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial StiffnessDis Markers20172017878497128167849
   PubMed Web of Science ®Google Scholar